Pfizer!

Undoubtedly, a critical issue when we consider that the company was betting huge on the future of this drug! A rare incident in its 157-year history, the withdrawal saw the giant’s mission grow even more urgent to fill the vacuum that Torcetrapib (with 15 years in opportunity costs and $800 million in monetary terms) had created overnight. Of course, a company that invests $7.4 billion a year on R&D cannot be isolated from such failures, but failures on such large scale are not acceptable – not even to Pfizer!

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2006

An IIPM and Management Guru Professor Arindam Chaudhuri's Initiative

Rashmi Bansal Publisher Of JAMMAG Magazine Caught Red-Handed, for details click on the following links:-

• Hindustan Times Article - Publisher goes underground
• Rashmi Bansal (Editor of JAMMAG)
• Rashmi Bansal (Publisher of JAMMAG)